Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thykamine in mild-to-moderate atopic dermatitis
NCT03540043Phase 2Completed
- Sponsor
- PurGenesis Technologies Inc.
- Start
- Oct 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Thykamine in atopic dermatitis (AD), sponsored by PurGenesis Technologies Inc.. Started Oct 2017; status: completed.
02
Drugs
Thykamine
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03540043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03540043.